The Effects of Oral Glucose Compared to Sweetener Drinking on Hormonal/Metabolic Responses
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this study is to determine the hormonal/metabolic reponse to ingestion of sugar compared to consuming artificial sweetened drink, and to evalute macronutrient consumption 24 hours post ingestion of the drinks.
We hypothesize that artificially sweetened (AS) consumption will lead to a relatively similar hormonal/metabolic responses as glucose consumption and therefore to secondary rise of caloric intake.
| Condition | Intervention |
|---|---|
|
Obesity |
Other: glucose Other: sweetner |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Single Blind (Subject) Primary Purpose: Screening |
| Official Title: | The Effects of Oral Glucose Compared to Sweetener Drinking on Hormonal/Metabolic Responses and 24 Hour Macronutrient Consumption - A Double Blind, Cross-over Study |
- Hormonal response [ Time Frame: 3 hours ] [ Designated as safety issue: No ]
All the participants will be checked for level of: insulin, glucose, adrenalin norepinephrine, dopamine, catecholamines, cortisol, ghrelin, leptin, IGF-1 GH- and other related hormones before consuming the drink (time 0), and 30, 60, 120, 180 minutes after.
The participants will be under medical supervision throughout the examination, including HR & BP montoring, and until 1 hour after
- food questionnaire [ Time Frame: 24 hours ] [ Designated as safety issue: No ]The participants will be receiving a- "24 hr food questionnaire" which they will fill during the day after consuming the drink followed by an interview in order to get the maximal information.
| Estimated Enrollment: | 24 |
| Study Start Date: | May 2013 |
| Estimated Study Completion Date: | March 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Oral glucose tolerance test
The participants will consume a beverage containing 75 gram glucose During the meeting, the participants will drink the sweetened drink followed by blood work, at 0, 30, 60, 120, 180 minutes. Also, they will record their macronutrient\caloric consumption during the 24 hour following the test.
|
Other: glucose
The participants will report to the lab after an overnight fast. Their BMI, HR and BP will be measured. An IV catheter will be inserted into the brachial vein and the participants will rest for half an hour. Participants will drink A beverage containing 75 gram glucose (oral glucose tolerance test (OGTT / GTT) All the participants will be checked for level of: insulin, glucose, adrenalin norepinephrine, dopamine, catecholamines, cortisol, ghrelin, leptin, IGF-1 GH and other related hormones- before consuming the drink (time 0), and at 30, 60, 120, 180 minutes after. The participants HR & BP will be monitored throughout the examination + 1 hour after. In addition, the participants will be asked to complete a- "24 hr food questionnaire". |
|
Placebo Comparator: Artificial sweetner
participants will consume a beverage containing 0.42 gram artificial sweetener (Aspartame) During each meeting, the participants will drink the sweetened drink followed by blood work, at 0, 30, 60, 120, 180 minutes. Also, they will record their macronutrient\caloric consumption during the 24 hour following the test. |
Other: sweetner
The participants will report to the lab after an overnight fast. Their BMI, HR and BP will be measured. An IV catheter will be inserted into the brachial vein and the participants will rest for half an hour. Participants will drink A beverage containing artificial sweetened drink. All the participants will be checked for level of: insulin, glucose, adrenalin norepinephrine, dopamine, catecholamines, cortisol, ghrelin, leptin, IGF-1 GH and other related hormones- before consuming the drink (time 0), and at 30, 60, 120, 180 minutes after. The participants HR & BP will be monitored throughout the examination + 1 hour after. In addition, the participants will be asked to complete a- "24 hr food questionnaire". |
Detailed Description:
During the last two decades, the prevalence of overweight and obesity doubled. at the same time, individuals have increasingly turned to artificially sweetened (AS) foods and beverages in an attempt to lose weight, or control it.
several studies have found that there may be a connection between artificially sweetened food and beverages consumption and paradoxical weight gain and increased incidence of metabolic syndrome. the causal relationship between AS use and weight gain haven't been proven yet.
The participants will be invited to 2 meetings in which they will consume, in a randomized double blind way:
- A beverage containing 75 gram glucose
- A beverage containing 0.42 gram artificially sweetener (Aspartame, similar sweetness level)
During each meeting, the participants will drink the sweetened drink followed by blood work, as done in oral glucose challenge or tolerance test (OGTT / GTT).
Also, they will record their macronutrient\caloric consumption during the 24 hour following the test.
Eligibility| Ages Eligible for Study: | 25 Years to 35 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Adults, healthy, men and women, ages 25-35 years, without any chronic illnesses.
Exclusion Criteria:
- Family history of diabetes or overweight with BMI> 27
- Use of drugs who can influence the glucose metabolism (exp: glucocorticoids).
Contacts and Locations| Contact: Dan Nemet, MD | 972-9-7471596 | Dan.Nemet@clalit.org.il |
| Israel | |
| Meir Medical Center | Not yet recruiting |
| Kfar-Saba, Israel | |
| Contact: Dan Nemet, MD 972-9-7471596 Dan.Nemet@clalit.org.il | |
| Principal Investigator: Dan Nemet, MD | |
| Principal Investigator: | Dan Nemet, MD | Meir Medical Center, Kfar-Saba, Israel |
More Information
No publications provided
| Responsible Party: | Dan Nemet, MD, MD, Prof. of Pediatric, Meir Medical Center |
| ClinicalTrials.gov Identifier: | NCT01683929 History of Changes |
| Other Study ID Numbers: | MeirMc017112CTIL |
| Study First Received: | September 10, 2012 |
| Last Updated: | April 25, 2013 |
| Health Authority: | Israel: Ethics Commission |
Keywords provided by Meir Medical Center:
|
Obesity Overweight Sugar consumption Metabolic syndrome Artificially sweetened foods and beverages |
Additional relevant MeSH terms:
|
Obesity Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013